Business Context and Reporting Period
Company: HealthEquity, Inc. (HQY)
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Three and six months ended July 31, 2026
Business Overview: HealthEquity is a leading administrator of Health Savings Accounts (HSAs) and complementary consumer-directed benefits (CDBs). As of July 31, 2026, the company administered 10.7 million HSAs with total assets of $37.9 billion and 7.0 million CDBs, totaling 17.8 million accounts.
Key Financial Metrics
| Metric (in thousands) | Three Months Ended July 31, 2026 |
Six Months Ended July 31, 2026 |
|---|---|---|
| Total Revenue | $350,732 | $705,373 |
| Net Income | $65,644 | $135,062 |
| Diluted EPS | $0.78 | $1.60 |
| Adjusted EBITDA | $166,981 | $331,469 |
| Cash and Cash Equivalents | $256,003 | $256,003 |
| Long-Term Debt (Net) | $931,062 | $931,062 |
| Operating Cash Flow (6mo) | N/A | $233,685 |
Revenue Breakdown (Six Months 2026): Service revenue ($247.4M), Custodial revenue ($350.3M), and Interchange revenue ($107.7M).
Debt Structure: Includes $600M in 4.50% Senior Notes due 2029 and $335M outstanding on a $1.0B Revolving Credit Facility.
Material Changes vs. Prior Period
- Revenue Growth: Total revenue increased 8% year-over-year (YoY) for the quarter and 7% YoY for the six-month period. Custodial revenue drove significant growth, up 10% (quarter) and 11% (six months), attributed to higher average annualized yields on HSA cash (3.83% vs. 3.51% prior year) and increased HSA assets.
- Profitability: Net income rose 10% for the quarter and 19% for the six months ended July 31, 2026, compared to the prior year. Gross margin improved as cost of revenue decreased 4% while revenue increased.
- Operating Expenses: Total operating expenses increased 11% (quarter) and 10% (six months). Notable increases included Technology and Development (up 14% and 12% respectively) due to software and cloud infrastructure investments, and General and Administrative expenses (up 16% and 19%) driven by stock-based compensation related to executive retirement.
- Balance Sheet: Cash and cash equivalents decreased from $318.9M to $256.0M, primarily due to $231.1M in common stock repurchases and $26.9M in debt prepayments during the six-month period.
Guidance, Outlook, and Risks
Management Commentary & Outlook:
- Interest Rates: Management expects custodial revenue to continue increasing as existing agreements with depository partners renew at higher rates and participation in the "Enhanced Rates" offering grows.
- Cost Efficiency: Service costs are expected to decrease as a percentage of revenue due to operational efficiencies from technology investments, despite rising account volumes.
- Investment Strategy: The company continues to invest in proprietary technology modernization and AI tools to improve customer service and efficiency.
Risks and Contingencies:
- Legal Proceedings: The company is subject to a consolidated putative class action lawsuit and regulatory inquiries regarding a cybersecurity incident in fiscal 2025 involving a business partner's user account. The company intends to vigorously defend itself, but the potential loss cannot be reasonably estimated.
- Regulatory Environment: Changes in U.S. tax law or healthcare policy (e.g., "Medicare for all") could materially impact the business model.
- Interest Rate Risk: While hedging strategies are in place, sustained declines in interest rates could reduce custodial revenue yields.
Investor Verification Checklist
- Cybersecurity Litigation Status: Monitor updates on the class action lawsuit and regulatory inquiries stemming from the fiscal 2025 data breach to assess potential financial exposure.
- Interest Rate Sensitivity: Verify the impact of the interest rate environment on the "Enhanced Rates" offering and the maturity schedule of HSA cash contracts.
- Stock Repurchase Program: Confirm the remaining authorization ($948.4M as of July 31, 2026) and the pace of future buybacks given the significant cash outflow in the current period.
- Technology Spend: Review the ROI on increased Technology and Development expenses to ensure they translate into the projected operational efficiencies.
- Debt Covenants: Verify continued compliance with the Credit Agreement's financial covenants (max 5.0x net leverage, min 3.0x interest coverage).